Key points are not available for this paper at this time.
A novel graphene-based composite, 5-methyl-1,3,4-thiadiazol-2-amine (MTA) covalently functionalized graphene oxide (GO-MTA), was rationally developed and used for the selective sorption of Ga
Zhu et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: